Correction: Fremanezumab in the prevention of high-frequency episodic and chronic migraine: a 12-week, multicenter, real-life, cohort study (the FRIEND study)

Detalles Bibliográficos
Autores principales: Barbanti, Piero, Egeo, Gabriella, Aurilia, Cinzia, d’Onofrio, Florindo, Albanese, Maria, Cetta, Ilaria, Di Fiore, Paola, Zucco, Maurizio, Filippi, Massimo, Bono, Francesco, Altamura, Claudia, Proietti, Stefania, Bonassi, Stefano, Vernieri, Fabrizio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Milan 2022
Materias:
Correction
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9172000/
https://www.ncbi.nlm.nih.gov/pubmed/35672670
http://dx.doi.org/10.1186/s10194-022-01434-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9172000/
https://www.ncbi.nlm.nih.gov/pubmed/35672670
http://dx.doi.org/10.1186/s10194-022-01434-8

Ejemplares similares